DuPont has introduced DuPont™ Liveo™ Pharma TPE Overmolded Assemblies designed for ultrapure fluid transfer in pharmaceutical and biopharmaceutical processes. These assemblies reduce contamination risk, leakage, and in-house assembly time and costs, supporting single-use systems with strong chemical resistance and low extractables. The customizable assemblies enhance flexibility for biopharma manufacturers and complement DuPont's existing portfolio of high-purity TPE solutions. They are suitable for critical applications like gene therapies and fill-and-finish operations, aiming to improve efficiency and safety in biopharmaceutical production.
DuPont has introduced a comprehensive Direct Lithium Extraction (DLE) portfolio featuring over 20 products, including sorbents, membranes, and ion exchange resins, designed to enhance lithium recovery from various brine compositions. This integrated ...
DuPont will release its financial results for the second quarter of 2026 on August 4 at 6:00 a.m. ET. The company will also hold a live conference call at 8:00 a.m. ET the same day, accessible via webcast and phone. Investors can find the earnings re...
